Mon, December 1, 2025 at 2:05 AM UTC Although they both face a similar headwind today, Pfizer and Bristol Myers Squibb have demonstrated that they can effectively address the challenges they encounter ...

Guests give high ratings to Perfect Day at CocoCay, Royal Caribbean's private island. Sometimes becoming the best in your field means realizing that it’s not your field at all. For Royal Caribbean ...

[Our innovation thought leadership interviews regularly explore the ongoing evolution happening in investment and risk management, but we also take deep dives into “niche” investment areas or specific ...

Most dividend investors seek solid passive income streams from quality dividend stocks. Passive income is a steady stream of unearned income that doesn’t require active traditional work. Shared ideas ...

I track a universe of 50 high-quality dividend growth stocks to identify attractive entry points based on valuation and future return potential. The investable universe outperformed SPY and SCHD since ...

High-quality AI outcomes largely depend on how data is captured, ingested and contextualized, especially in AI that is purpose-built for your industry.

Good companies don't go on sale very often. When they do, you should pay close attention. Right now two of the world's largest consumer staples companies are both attractively priced, one more so than ...

Consumer staples companies tend to have resilient businesses. Dividend Kings have proven they know how to survive hard times. These two undervalued companies are both consumer staples giants and ...

Drug companies face fairly normal industry dynamics that can leave them unloved on Wall Street over short periods of time. Pfizer is facing a patent cliff and is making a big move to revamp its drug ...

Investor jitters over Meta’s artificial intelligence (AI) spending are overblown. Meta’s Family of Apps are so profitable that it can afford to take risks on big ideas. Disney has finally found its ...